Literature DB >> 21717106

Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.

Rita A Mukhtar1, Amy P Moore, Onouwem Nseyo, Frederick L Baehner, Alfred Au, Dan H Moore, Patrick Twomey, Michael J Campbell, Laura J Esserman.   

Abstract

African American and Hispanic women develop more triple negative breast cancer at younger ages than Caucasian women. The frequently observed association between race and socioeconomic status (SES) has confounded our understanding of the outcomes disparities seen in these groups. Given the association between inflammatory cells and high-grade, triple negative tumors, we sought to investigate whether differences in the presence of these cells varies by race. We evaluated breast tumor specimens for the presence PCNA+ tumor-associated macrophages (TAMs) in consecutive cases from a county hospital serving primarily un- or under-insured patients. All patients in this cohort had elevated PCNA + TAM levels. Higher PCNA + TAM counts were associated with hormone receptor (HR) negative tumors and non-Caucasian ethnicity. Hispanic women specifically had significantly higher PCNA + TAM counts than Caucasian patients and shorter disease-free survival. These findings implicate immune function in the development of aggressive breast cancer and suggest a possible link between SES and the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717106     DOI: 10.1007/s10549-011-1646-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  26 in total

Review 1.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

Review 2.  Nuevo Amanecer: results of a randomized controlled trial of a community-based, peer-delivered stress management intervention to improve quality of life in Latinas with breast cancer.

Authors:  Anna María Nápoles; Carmen Ortíz; Jasmine Santoyo-Olsson; Anita L Stewart; Steven Gregorich; Howard E Lee; Ysabel Durón; Peggy McGuire; Judith Luce
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

Review 3.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

Review 4.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

Review 5.  Analysis of Tumor Biology to Advance Cancer Health Disparity Research.

Authors:  Cheryl J Smith; Tsion Z Minas; Stefan Ambs
Journal:  Am J Pathol       Date:  2017-11-11       Impact factor: 4.307

6.  Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Wei Qing; Wei-Yuan Fang; Lei Ye; Li-Yun Shen; Xiao-Fang Zhang; Xiao-Chun Fei; Xi Chen; Wei-Qing Wang; Xiao-Ying Li; Jia-Cheng Xiao; Guang Ning
Journal:  Thyroid       Date:  2012-08-07       Impact factor: 6.568

Review 7.  Are macrophages in tumors good targets for novel therapeutic approaches?

Authors:  Samthosh V Alahari; Shengli Dong; Suresh K Alahari
Journal:  Mol Cells       Date:  2014-12-16       Impact factor: 5.034

Review 8.  Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Authors:  Sachin Kumar Deshmukh; Sanjeev K Srivastava; Nikhil Tyagi; Aamir Ahmad; Ajay P Singh; Ahmed A L Ghadhban; Donna L Dyess; James E Carter; Kari Dugger; Seema Singh
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

9.  Carcinoembryonic antigen-related cell adhesion molecule 1 negatively regulates granulocyte colony-stimulating factor production by breast tumor-associated macrophages that mediate tumor angiogenesis.

Authors:  Sridhar Samineni; Zhifang Zhang; John E Shively
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

10.  Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes.

Authors:  Raffaella Sabatino; Serafina Battistelli; Mauro Magnani; Luigia Rossi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.